Torch Wealth Management LLC Has $1.59 Million Stock Holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Torch Wealth Management LLC cut its position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 0.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,613 shares of the financial services provider’s stock after selling 140 shares during the period. Torch Wealth Management LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $1,594,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of IBB. Global Trust Asset Management LLC boosted its stake in iShares Nasdaq Biotechnology ETF by 89,733.3% during the 2nd quarter. Global Trust Asset Management LLC now owns 32,340 shares of the financial services provider’s stock valued at $32,000 after purchasing an additional 32,304 shares during the last quarter. Trustcore Financial Services LLC acquired a new position in iShares Nasdaq Biotechnology ETF during the 1st quarter valued at about $34,000. Meridian Wealth Management LLC acquired a new position in iShares Nasdaq Biotechnology ETF during the 1st quarter valued at about $36,000. Signaturefd LLC boosted its stake in iShares Nasdaq Biotechnology ETF by 59.2% during the 2nd quarter. Signaturefd LLC now owns 328 shares of the financial services provider’s stock valued at $36,000 after purchasing an additional 122 shares during the last quarter. Finally, Destination Wealth Management acquired a new position in iShares Nasdaq Biotechnology ETF during the 1st quarter valued at about $42,000. Institutional investors own 74.63% of the company’s stock.

IBB stock traded down $0.15 during mid-day trading on Thursday, reaching $102.88. 160,939 shares of the company traded hands, compared to its average volume of 2,203,167. iShares Nasdaq Biotechnology ETF has a fifty-two week low of $89.01 and a fifty-two week high of $122.97. The company has a 50 day simple moving average of $106.29.

About iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Read More: Stock Symbols Definition, Examples, Lookup

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.